NFKB1 and depressive symptom measurement: In this context, NF-κB has been hypothesized to stimulate the release of inflammatory mediators, including TNF-α, interleukin (IL)-1β, and IL-6, as well as promoting neuroinflammatory processes, finally leading to depression [57].